🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized study in subjects with heterozygous famil...
Status
Completed
Location
IMD Medical Group
Start Date
2013-10-23
Trial ID
NCT01968980
Treatments Being Tested
This study is a multicenter, double-blind, randomized study to access the e...
Status
Completed
Location
Advanced Cardiovascular, LLC Research
Start Date
2014-10-28
Trial ID
NCT02100514
Treatments Being Tested
This study aims to characterize the single dose pharmacokinetics of PF-0495...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2014-04
Trial ID
NCT02043301
This study is a multicenter, randomized study in subjects with high cholest...
Status
Completed
Location
Ernest L. Hendrix, MD, PC
Start Date
2013-10-29
Trial ID
NCT01968967
Treatments Being Tested
This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), ...
Status
Terminated
Location
Ernest Hendrix, MD, PC
Start Date
2013-10-29
Trial ID
NCT01975376
Treatments Being Tested
The study is designed to determine the safety and tolerability of RN316 whe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-11
Trial ID
NCT00991159
Treatments Being Tested
This study evaluates the PCSK9 inhibitor, Bococizumab (PF-04950615;RN316), ...
Status
Terminated
Location
Ernest Hendrix, MD, PC
Start Date
2013-10-29
Trial ID
NCT01975389
Treatments Being Tested
The primary objective of this study is to evaluate the pharmacokinetics and...
Status
Completed
Location
Premier Research Group, Limited
Start Date
2010-07
Trial ID
NCT01163851
This study is a Phase 3, double blind, placebo controlled, randomized, stra...
Status
Withdrawn
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2016-10-31
Trial ID
NCT02947334
Treatments Being Tested
This is a Phase 1, open-label, single-dose, randomized, dose escalation stu...
Status
Terminated
Location
Pfizer Clinical Research Unit
Start Date
2016-02
Trial ID
NCT02667223